tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB

Inmune Bio (INMB) Stock Investors

265 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold INMB
On average, investors allocate 0.00% of their portfolios to INMB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding INMB

1.3%
Last 7
Days
3.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding INMB, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

INMB Investor Activity

No data currently available
Based on the activity of 13,683 investors who made their portfolios public
The table shows changes in INMB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

INMB Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.19%
-1.26%
-3.57%
37.89B
Consumer Cyclical
ChargePoint Holdings
3.92%
-0.91%
-7.35%
668.91M
Consumer Cyclical
Riot Platforms
4.74%
-1.51%
+0.37%
2.17B
Financial
Merck & Company
4.12%
-0.04%
-0.41%
319.59B
Healthcare
Marathon Digital Holdings
5.39%
-0.26%
-3.45%
4.28B
Financial
Coherus Biosciences
2.65%
-1.32%
-8.34%
245.00M
Healthcare
GE Aerospace
5.53%
+1.08%
+6.09%
168.04B
Industrials
Mercadolibre
5.29%
+0.14%
-2.46%
71.78B
Consumer Cyclical
Block
4.49%
-1.08%
-7.00%
45.25B
Technology
Blink Charging Co
5.07%
-1.37%
-6.36%
231.28M
Industrials
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

INMB Investor Analysis

INMB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.6%
of INMB holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
INMB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.2%
of INMB holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
INMB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
45.1%
of INMB holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of INMB stock investors
See who invests in INMB according to age group and performance.

FAQ

How many retail Investors hold INMB?
<0.1% of TipRanks' retail investors hold INMB in their portfolios.
    What is INMB Investor Sentiment?
    INMB’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of INMB in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of INMB in the last 7 days.
        What percentage of retail investors changed their holding of INMB in the last 30 days?
        ▼ 3.1% of TipRanks' retail investors changed their holding of INMB in the last 30 days.
          What is the average age of retail investors who hold INMB?
          The average age of INMB Holders is over 55.
            What other stocks have INMB investors also bought?
            INMB Investors also bought DKNG, CHPT, RIOT, MRK, MARA, CHRS, GE, MELI, SQ, BLNK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis